KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Other Non-Current Liabilities (2016 - 2023)

Historic Other Non-Current Liabilities for Palvella Therapeutics (PVLA) over the last 9 years, with Q4 2023 value amounting to $1.0 million.

  • Palvella Therapeutics' Other Non-Current Liabilities changed N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Palvella Therapeutics' Other Non-Current Liabilities is $1.0 million.
  • Palvella Therapeutics' Other Non-Current Liabilities' 5-year high stood at $12.3 million during Q2 2019, with a 5-year trough of $6000.0 in Q4 2020.
  • For the 3-year period, Palvella Therapeutics' Other Non-Current Liabilities averaged around $5.1 million, with its median value being $1.0 million (2023).
  • Examining YoY changes over the last 5 years, Palvella Therapeutics' Other Non-Current Liabilities showed a top increase of 3765625.0% in 2019 and a maximum decrease of 2702.7% in 2019.
  • Over the past 3 years, Palvella Therapeutics' Other Non-Current Liabilities (Quarter) stood at $12.1 million in 2019, then crashed by 99.95% to $6000.0 in 2020, then skyrocketed by 16800.0% to $1.0 million in 2023.
  • Its Other Non-Current Liabilities stands at $1.0 million for Q4 2023, versus $6000.0 for Q4 2020 and $12.1 million for Q3 2019.